consid
respons
tumor
growth
chemoresist
differ
hypothes
propos
explain
origin
cic
includ
mutat
adult
stem
progenitor
cell
acquisit
stemlik
characterist
differenti
cell
howev
studi
yield
conflict
identif
cic
littl
inform
origin
gener
cic
part
difficulti
identifi
cic
may
stem
fact
cic
studi
larg
deriv
cancer
cell
line
welldevelop
tumor
previou
studi
report
enrich
mous
pulmonari
stemprogenitor
cell
mpsc
use
serumfre
primari
select
cultur
follow
fac
isol
use
coxsackieviru
adenoviru
receptor
car
posit
select
marker
demonstr
overexpress
pluripot
transcript
factor
suffici
induc
car
mpsc
transform
name
car
mpsc
transform
cell
possess
cancer
initi
chemoresist
potenti
well
exhibit
remark
express
certain
proangiogen
factor
includ
angiopoietin
ang
vegf
enhanc
angiogen
potenti
moreov
car
mpsc
activ
particip
tumor
blood
vessel
format
trigger
novel
angiogen
mechan
signal
pathway
studi
provid
critic
evid
support
possibl
origin
gener
cic
help
elucid
pathway
respons
cicsmedi
blood
vessel
format
lung
cancer
lead
caus
cancerrel
death
worldwid
overal
surviv
rate
remain
less
increas
evid
suggest
cancer
stem
cell
also
known
cancer
initi
cell
cic
play
critic
role
tumor
growth
resist
convent
chemotherapi
may
respons
tumor
metastasi
recurr
cic
identifi
use
differ
vitro
assay
cell
biomark
side
popul
analysi
sphere
format
assay
chemoresist
aldehyd
dehydrogenas
aldh
activ
cell
marker
howev
vitro
assay
alon
wwwimpactjournalscomoncotarget
enough
demonstr
identifi
cell
fact
cic
therefor
certain
vivo
assay
limit
dilut
transplant
experi
anim
model
use
verifi
result
vitro
assay
unfortun
studi
yield
conflict
identif
cic
differ
type
cancer
discrep
cic
identif
may
due
fact
studi
cell
deriv
differ
cancer
cell
line
welldevelop
tumor
phenotyp
function
heterogen
clinic
tumor
sampl
may
exacerb
difficulti
identifi
cic
differ
hypothes
propos
explain
format
cic
mutat
adult
stemprogenitor
cell
acquisit
stemlik
characterist
differenti
cell
howev
sourc
cell
process
involv
develop
cic
remain
unclear
kra
mutat
condit
mice
model
stem
cell
locat
bronchioalveolar
duct
junction
examin
potenti
origin
adenocarcinoma
crelox
mediat
activ
anoth
studi
demonstr
mediat
igfir
signal
form
complex
play
crucial
role
selfrenew
oncogen
potenti
cic
lung
adenocarcinoma
addit
coexpress
nanog
lung
adenocarcinoma
cell
line
control
epithelialmesenchym
transdifferenti
regul
tumor
initi
abil
promot
metastasi
behavior
moreov
high
level
nonsmal
cell
lung
cancer
patient
correl
metastasi
lower
surviv
rate
although
studi
demonstr
certain
pluripot
gene
nanog
close
associ
tumor
initi
properti
connect
aberr
pluripot
gene
express
gener
cic
unclear
requir
clarif
studi
gener
cic
anim
model
better
understand
properti
characterist
cic
hope
find
may
aid
cancer
research
provid
insight
earli
diagnosi
treatment
lung
cancer
previou
studi
enrich
mous
pulmonari
stemprogenitor
cell
mpsc
use
serumfre
primari
select
cultur
follow
fac
isol
use
coxsackievirusadenoviru
receptor
car
posit
select
marker
cultur
car
mpsc
exhibit
stemprogenitor
properti
could
differenti
typei
pneumocyt
possess
angiogen
potenti
hypothes
car
mpsc
could
transform
via
overexpress
would
develop
typic
cic
phenotyp
test
typei
pneumocyt
deriv
car
mpsc
well
experi
describ
examin
characterist
transform
cell
use
vitro
assay
includ
cell
cycl
telomeras
activ
analysi
sphere
form
assay
detect
express
aldh
activ
chemoresist
assay
addit
vivo
assay
includ
limit
dilut
transplant
tumor
metastasi
assay
scid
mice
use
studi
characterist
transform
cell
sinc
capac
induc
angiogenesi
anoth
trait
cic
endotheli
tube
format
assay
ovo
chicken
chorioallanto
membran
cam
assay
use
evalu
angiogen
potenti
transform
cell
result
help
elucid
possibl
origin
pathway
gener
cic
help
uncov
cic
may
regul
blood
vessel
format
tissu
specif
stem
cell
small
number
yet
larg
respons
tissu
homeostasi
previou
studi
success
identifi
isol
car
mpsc
supplementari
figur
compar
mous
embryon
stem
cell
line
car
mpsc
low
express
level
nanog
pcr
realtim
pcr
analysi
supplementari
figur
car
mpsc
show
potenti
differenti
typei
pneumocyt
day
evidenc
flatten
cellular
morpholog
presenc
typei
pneumocyt
marker
supplementari
figur
thu
car
mpsc
possess
pulmonari
specif
stemprogenitor
cell
properti
cell
identifi
accord
car
express
effici
isol
use
fac
overexpress
retroviru
transfect
perform
car
mpsc
car
mpscsderiv
typei
pneumocyt
experi
car
mpsc
transfect
figur
feeder
cell
suppli
day
figur
iii
cobblestonelik
coloni
first
observ
form
day
day
day
welldevelop
coloni
exhibit
phasebright
border
cell
within
coloni
high
nuclear
cytoplasm
ratio
promin
nucleoli
figur
iv
coloni
pick
expand
gener
cell
clone
figur
v
frequenc
cobblestonelik
coloni
format
car
mpsc
rang
figur
meanwhil
cobblestonelik
coloni
observ
sham
control
transfect
car
mpsc
data
shown
retrovir
transfect
car
mpscsderiv
typei
pneumocyt
perform
day
typei
pneumocyt
welldifferenti
supplementari
figur
result
indic
overexpress
induc
cobblestonelik
coloni
format
car
mpsc
cell
statu
stemprogenitor
stage
rather
differenti
stage
appear
critic
induct
coloni
via
overexpress
cobblestonelik
coloni
isol
establish
separ
cell
clone
evalu
phenotyp
alter
cell
clone
independ
experi
name
select
examin
western
blot
analysi
show
highli
express
clone
thu
refer
car
mpsc
clone
supplementari
figur
express
level
clone
similar
mous
embryon
stem
cell
line
wherea
car
mpsc
exhibit
low
express
supplementari
figur
ii
primari
cultur
car
specif
express
pulmonari
stemprogenitor
cell
serv
marker
car
mpsc
isol
car
mpsc
clone
car
express
cell
cell
lost
capac
differenti
typei
pneumocyt
data
shown
cell
cycl
analysi
show
signific
g
sand
g
mphase
shift
car
mpsc
car
mpsc
clone
figur
addit
clone
could
propag
passag
doubl
time
h
telomeras
activ
detect
th
th
th
passag
clone
detect
car
mpsc
figur
result
demonstr
hyperexpress
car
mpsc
suffici
produc
immort
effect
g
cell
cycl
progress
prolifer
potenti
telomeras
activ
order
evalu
pluripot
potenti
car
mpsc
clone
teratoma
format
assay
perform
clone
cell
clone
subcutan
implant
scid
mice
teratoma
approxim
cm
develop
supplementari
figur
show
repres
imag
histopatholog
analysi
clone
hematoxylin
eosin
h
e
stain
show
ectoderm
mesoderm
endoderm
lineag
differenti
absent
tumor
moreov
tumor
exhibit
typic
malign
phenotyp
characterist
high
cellular
densiti
small
round
immatur
cell
prolifer
pleomorph
cell
high
nuclearcytoplasm
ratio
high
mitot
ratio
supplementari
figur
use
immunohistochem
stain
car
detect
tumor
supplementari
figur
activ
form
oncogen
includ
phosphosrc
cmyc
cyclin
also
detect
tumor
supplementari
figur
lung
adenocarcinoma
diagnost
marker
thyroid
transcript
napsin
napsa
cytokeratin
cytokeratin
heavi
molecular
weight
ckhmw
also
detect
tumor
supplementari
figur
data
impli
car
mpsc
acquir
tumorigen
capac
hyperexpress
quantifi
tumorigen
potenti
car
mpsc
clone
anchorageindepend
growth
evalu
use
soft
agar
coloni
format
assay
week
clone
form
signific
soft
agar
coloni
number
compar
human
lung
adenocarcinoma
cell
line
howev
coloni
observ
car
mpsc
figur
evalu
secondari
sphere
format
effici
clone
cultur
nonadhes
condit
secondari
sphere
form
effici
car
mpsc
clone
significantli
higher
cell
sphere
format
also
absent
car
mpsc
figur
assay
clone
exhibit
pronounc
tumorigen
behavior
includ
highest
prolifer
rate
highest
effici
anchorageindepend
coloni
format
secondari
sphere
gener
therefor
clone
select
subsequ
vivo
tumorigen
experi
determin
tumorigen
clone
perform
limit
dilut
transplant
experi
tumor
format
potenc
figur
phenotyp
alter
car
mpsc
alter
cell
cycl
distribut
popul
g
g
mphase
cell
cycl
analyz
car
mpsc
car
mpsc
clone
data
present
mean
sd
sand
g
mphase
popul
car
mpsc
clone
strongli
increas
p
compar
car
mpsc
b
telomeras
activ
car
mpsc
car
mpsc
clone
clone
evalu
th
th
th
passag
car
denot
car
mpsc
h
denot
heat
inactiv
cell
concentr
clone
inject
respect
addit
low
cell
concentr
clone
suffici
tumor
format
averag
inject
figur
tumor
size
morpholog
shown
figur
ii
contrast
tumor
format
observ
transplant
use
car
mpsc
cell
despit
incub
data
shown
order
examin
metastat
potenti
cell
clone
transplant
tail
vein
mice
allow
develop
mice
inject
clone
develop
tumor
nodul
lung
tissu
figur
h
e
stain
lung
tissu
reveal
extens
hemorrhag
nodul
format
clone
transplant
abnorm
lesion
detect
car
mpsc
transplant
kaplanmei
surviv
analysi
perform
determin
surviv
rate
follow
clone
car
mpsc
transplant
mean
surviv
mice
inject
clone
significantli
lower
mice
transplant
car
mpsc
figur
result
suggest
car
mpsc
undergo
malign
transform
follow
hyperexpress
evidenc
vitro
vivo
tumorigen
potenti
tumor
initi
capac
car
mpsc
clone
differ
biomark
lung
cic
propos
includ
express
aldh
activ
chemoresist
util
biomark
investig
cic
characterist
car
mpsc
clone
flow
cytometri
analysi
reveal
cell
among
clone
wherea
cell
nearli
undetect
car
mpsc
figur
aldh
activ
detect
clone
wherea
car
mpsc
exhibit
aldh
activ
figur
chemoresist
also
critic
biolog
featur
cic
evalu
clone
chemoresist
cisplatin
paclitaxel
treatment
cell
viabil
shown
figur
ic
valu
cisplatin
clone
indic
car
mpsc
hi
clone
fold
resist
cisplatin
compar
cell
paclitaxel
ic
nm
clone
approxim
fold
higher
cell
figur
iii
well
document
protein
survivin
inhibit
apoptosi
play
import
role
confer
chemoresist
cic
found
survivin
express
significantli
higher
figur
vitro
tumorigen
phenotyp
car
mpsc
soft
agar
coloni
format
assay
car
mpsc
car
mpsc
clone
subject
soft
agar
cultur
coloni
photograph
quantifi
wk
b
sphere
format
assay
car
mpsc
car
mpsc
clone
subject
sphere
format
assay
secondari
sphere
photograph
quantifi
scale
bar
c
quantif
coloni
sphere
data
present
mean
sd
clone
compar
car
mpsc
figur
clone
also
exhibit
lower
level
cleav
cleav
cisplatin
paclitaxel
treatment
compar
car
mpsc
figur
ii
taken
togeth
result
suggest
hyperexpress
drive
transform
car
mpsc
confer
cicslik
properti
previou
studi
car
mpsc
shown
express
proangiogen
factor
includ
vascular
endotheli
growth
factor
vegfa
granulocyt
coloni
stimul
factor
gcsf
vascular
cell
adhes
molecul
basic
fibroblast
growth
factor
bfgf
initi
endotheli
cell
tube
format
therefor
want
evalu
potenti
angiogenesi
car
mpsc
clone
perform
realtim
pcr
analysi
found
proangiogen
factor
includ
angiopoietin
angiopoietin
vegfa
placent
growth
factor
plgf
plateletderiv
growth
factor
pdgfa
gcsf
bfgf
express
significantli
higher
level
clone
compar
car
mpsc
figur
confirm
angiogen
potenti
use
clone
car
mpsc
cam
assay
implant
cam
clone
induc
extens
blood
vessel
format
compar
car
mpsc
implant
supplementari
figur
branch
point
quantif
reveal
implant
clone
significantli
increas
blood
vessel
branch
compar
car
mpsc
growth
curv
tumor
differ
concentr
clone
cell
subcutan
inject
scid
mice
tumor
diamet
measur
use
calip
indic
time
inject
data
present
mean
sd
ii
tumor
excis
photograph
measur
day
inject
scale
bar
cm
b
metastat
tumor
nodul
format
clone
cell
inject
tail
vein
scid
mice
car
mpsc
inject
nativ
control
metastat
tumor
nodul
format
lung
record
wk
indic
arrow
h
e
stain
mice
inject
clone
show
extens
hemorrhag
nodul
format
magnifi
imag
clone
show
nodul
lung
tissu
scale
bar
c
kaplanmei
surviv
curv
car
mpscsand
cloneinject
mice
n
supplementari
figur
immunohistochem
analysi
quantif
clonederiv
tumor
reveal
significantli
higher
popul
found
deriv
tumor
supplementari
figur
data
suggest
hyperexpress
may
enhanc
angiogen
potenti
car
mpsc
clone
elucid
function
contribut
car
mpsc
angiogenesi
monitor
tube
format
endotheli
cell
incub
clone
clonederiv
sphere
label
green
fluoresc
tracer
calceinam
mix
cell
label
red
fluoresc
tracer
cocultur
tube
format
clonederiv
sphere
recruit
cell
establish
tube
network
figur
timelaps
architectur
video
use
confoc
microscopi
shown
supplementari
figur
put
cic
trait
car
mpsc
flow
cytometri
analysi
express
car
mpsc
car
mpsc
clone
percentag
indic
popul
clone
b
flow
cytometri
analysi
aldh
activ
result
aldefluor
assay
car
mpsc
car
mpsc
clone
shown
deabtreat
sampl
serv
neg
control
percentag
indic
aldhposit
popul
clone
c
cell
viabil
car
mpsc
car
mpsc
clone
cell
treat
cisplatin
ii
paclitaxel
nm
h
data
shown
mean
sd
p
p
compar
cell
iii
ic
cisplatin
paclitaxel
car
mpsc
clone
cell
data
shown
mean
sd
antiapoptosi
potenti
car
mpsc
clone
survivin
express
car
mpsc
car
mpsc
clone
analyz
use
western
blot
ii
cleav
c
cleav
c
level
car
mpsc
car
mpsc
clone
cisplatin
nm
paclitaxel
treatment
clone
cell
observ
integr
cell
tube
network
figur
architectur
video
tube
format
shown
supplementari
cultur
clone
endotheli
cell
growth
medium
egm
lonza
examin
tube
format
abil
car
mpsc
also
cultur
control
egm
cultur
clone
exhibit
tube
format
abil
wherea
capabl
observ
car
mpsc
cultur
egm
supplementari
figur
result
indic
car
mpsc
clone
possess
angiogen
potenti
also
involv
tube
format
vitro
evalu
tumor
blood
vessel
format
potenti
vivo
clone
transfect
gfp
express
clone
use
form
tumor
via
subcutan
implant
scid
mice
use
immunofluoresc
stain
endotheli
antigen
includ
vwf
detect
clonederiv
tumor
blood
vessel
incomplet
express
endotheli
antigen
figur
angiogenesi
potenti
car
mpsc
gene
express
level
proangiogen
factor
car
mpsc
car
mpsc
clone
analyz
use
realtim
pcr
data
present
mean
sd
p
p
compar
car
mpsc
b
vitro
tube
format
assay
cell
clonederiv
sphere
stain
calceinam
respect
cocultiv
matrigel
tube
format
record
fluoresc
confoc
microscopi
h
clonederiv
sphere
recruit
cell
gener
tube
network
c
proport
clone
cell
indic
arrow
observ
integr
tube
network
magnifi
imag
tube
network
depict
integr
clone
cell
scale
bar
immunofluoresc
stain
express
endotheli
antigen
clonederiv
tumor
identifi
ii
vwf
identifi
iii
identifi
magnifi
imag
show
gfp
cell
involv
blood
vessel
format
indic
arrow
proport
gfp
cell
also
express
indic
asterisk
scale
bar
e
express
dissoci
tumor
clone
analyz
use
flow
cytometri
subfract
repres
endotheli
cell
constitut
whole
tumor
popul
gfp
express
found
endotheli
cell
subfract
wwwimpactjournalscomoncotarget
gfp
cell
directli
integr
blood
vessel
exhibit
mosaiclik
pattern
moreov
endotheli
cell
simultan
express
endotheli
antigen
gfpposit
figur
confirm
presenc
gfp
endotheli
cell
examin
dissoci
tumor
use
flow
cytometri
similar
result
immunofluoresc
stain
popul
also
posit
gfp
figur
order
examin
correl
car
mpsc
clone
endotheli
cell
use
realtim
pcr
analyz
gene
express
angiogenesi
associ
receptor
vegf
receptor
receptor
specif
express
endotheli
cell
significantli
elev
egm
cultur
clone
compar
car
mpsc
gene
express
show
signific
differ
figur
western
blot
analysi
confirm
involv
erk
signal
pathway
show
phosphoerk
express
significantli
increas
egm
cultur
clone
rel
car
mpsc
figur
data
suggest
car
mpsc
activ
particip
tumor
angiogenesi
rather
play
passiv
role
car
mpsc
cancer
stem
cell
theori
propos
small
minor
tumor
cell
crucial
tumor
initi
progress
cell
share
common
characterist
properti
stem
cell
enabl
tumor
metastasi
recurr
chemoresist
recent
order
clarifi
cancer
initi
properti
cell
cancer
stem
cell
also
refer
cic
although
differ
cic
identifi
tumor
origin
cic
still
unclear
articl
report
overexpress
high
level
subset
pulmonari
stemprogenitor
cell
car
mpsc
transform
cell
exhibit
tumorigen
potenti
cicslik
properti
transform
cell
show
enhanc
angiogen
potenti
also
activ
particip
tumor
blood
vessel
format
activ
signal
pathway
one
import
transcript
factor
embryon
stem
cell
also
one
four
yamanaka
factor
known
induc
pluripot
overexpress
somat
cell
studi
kim
colleagu
alon
suffici
induc
pluripot
adult
neural
stem
cell
result
indic
play
critic
role
maintain
cell
pluripot
howev
chiou
et
al
demonstr
coexpress
nanog
induc
tumor
initi
abil
promot
metastasi
behavior
lung
adenocarcinoma
beltran
et
al
indic
overexpress
differ
primari
human
epitheli
breast
cell
prepar
gener
cell
line
possess
tumor
initi
colon
capabl
origin
cell
clearli
identifi
furthermor
hochedling
et
al
report
ectop
express
caus
intestin
epitheli
dysplasia
dysplast
lesion
show
expans
progenitor
cell
requir
continu
express
despit
associ
precis
role
cell
transform
remain
unclear
studi
found
car
mpsc
express
low
level
figur
signal
analysi
egm
cultur
car
mpsc
realtim
pcr
analyz
gene
express
angiogenesi
associ
receptor
includ
egm
cultur
car
mpsc
clone
car
mpsc
data
present
mean
sd
p
compar
car
mpsc
b
western
blot
analyz
signal
activ
egm
cultur
car
mpsc
clone
car
mpsc
includ
erk
phosphoerk
express
overexpress
could
transform
car
mpsc
form
cobblestonelik
coloni
contrast
coloni
observ
also
overexpress
welldifferenti
typei
pneumocyt
deriv
car
mpsc
thu
compar
studi
result
overexpress
adult
neural
stem
cell
specul
format
cobblestonelik
coloni
via
overexpress
depend
cell
type
differenti
statu
studi
clone
three
independ
experi
use
examin
western
blot
confirm
high
express
level
transform
cell
thu
term
car
mpsc
phenotyp
analysi
car
mpsc
clone
exhibit
longterm
prolifer
behavior
signific
shift
cell
cycl
g
sand
g
mphase
indic
cell
cycl
progress
also
found
telomeras
activ
continu
express
car
mpsc
clone
telomeras
activ
consid
confer
cell
cycl
progress
immort
growth
properti
taken
togeth
result
demonstr
car
mpsc
clone
exhibit
gener
phenotyp
immort
cell
properti
may
maintain
pluripot
evalu
pluripot
clone
vivo
teratoma
format
assay
standard
tool
monitor
pluripot
employ
histolog
analysi
tissu
deriv
car
mpsc
clone
show
differenti
three
germ
layer
h
e
stain
tissu
indic
malign
phenotyp
characterist
immunohistolog
examin
reveal
heterogen
phenotyp
express
oncogen
includ
phosphosrc
cmyc
cyclin
also
detect
tumorlik
tissu
diagnost
marker
lung
adenocarcinoma
napsa
ckhmw
result
indic
car
mpsc
clone
induc
tumor
format
deriv
heterogen
tumor
cell
popul
rather
teratoma
format
cic
defin
selfrenew
pluripot
capac
contribut
cancer
initi
progress
metastasi
recurr
chemoresist
assay
measur
anchorageindepend
growth
sphere
format
abil
gener
use
evalu
selfrenew
differenti
capac
cic
result
show
car
mpsc
clone
possess
higher
capac
coloni
format
soft
agar
sphere
format
compar
cell
demonstr
car
mpsc
clone
share
certain
trait
cic
vivo
assay
regard
gold
standard
perform
includ
limit
dilut
transplant
experi
anim
model
use
clone
demonstr
low
concentr
cell
transplant
cell
could
gener
tumor
frequenc
within
tumorigen
greater
report
side
popul
cell
concentr
gave
rise
tumor
frequenc
within
thu
car
mpsc
show
remark
tumor
initi
potenti
addit
cell
display
abil
metastasi
malign
mice
inject
clone
develop
tumor
nodul
lung
tissu
histopatholog
stain
lung
tissu
reveal
extens
hemorrhag
addit
vitro
vivo
assay
analyt
protocol
use
cic
identif
lung
cancer
includ
express
aldh
activ
chemoresist
assay
use
verifi
characterist
clone
although
mechan
underli
transform
hyperexpress
remain
elus
result
show
hyperexpress
directli
transform
car
mpsc
cicslik
properti
well
express
higher
aldh
activ
cisplatin
paclitaxel
resist
addit
studi
car
mpsc
also
exhibit
mark
survivin
express
regul
express
report
survivin
function
key
regul
mitosi
apoptosi
inhibit
act
inhibitor
li
et
al
report
posit
regul
survivin
express
promot
cancer
cell
prolifer
esophag
squamou
cell
carcinoma
specul
promot
cell
prolifer
attenu
apoptosi
may
critic
hyperexpress
induc
transform
may
mediat
via
survivin
well
known
growth
prolifer
metastasi
cancer
cell
highli
depend
angiogenesi
antiangiogen
therapi
consid
promis
strategi
cancer
treatment
vegf
signal
pathway
target
three
major
antiangiogen
drug
approv
clinic
use
howev
recent
studi
reveal
endotheli
cell
deriv
tumor
cell
resist
antivegf
therapi
recent
studi
report
cic
may
crucial
sourc
key
proangiogen
factor
cancer
exhibit
potent
angiogen
capac
glioma
ovarian
cancer
addit
soda
et
al
demonstr
tumor
initi
cell
glioblastoma
present
transdifferenti
potenti
gener
tumorderiv
vascular
endotheli
cell
hypoxia
stimul
previou
studi
car
mpsc
demonstr
express
proangiogen
factor
vegf
bfgf
induc
tube
format
endotheli
cell
vitro
vivo
studi
found
car
mpsc
clone
express
abund
proangiogen
factor
induc
angiogenesi
tube
format
cam
assay
surprisingli
found
car
mpsc
clone
activ
particip
tube
format
creat
mosaiclik
pattern
clone
cell
integr
tube
network
cell
earli
report
chang
colleagu
show
endotheli
cell
tumor
cell
form
lumin
surfac
presenc
mosaic
vessel
tomaso
et
al
demonstr
mosaic
structur
endothelium
vessel
human
colon
carcinoma
xenograft
mice
anim
model
studi
clone
deriv
gfp
express
cell
could
also
particip
form
tumor
blood
vessel
clone
deriv
tumor
flow
cytometri
analysi
clone
deriv
tumor
reveal
endotheli
cell
also
express
gfp
indic
popul
cell
deriv
clone
collect
result
indic
car
mpsc
exhibit
remark
angiogen
potenti
activ
particip
tumor
angiogenesi
order
specul
mechan
car
mpsc
clone
particip
angiogenesi
studi
found
car
mpsc
effect
switch
novel
angiogen
mechan
signal
pathway
ang
ligand
endotheliumspecif
receptor
tyrosin
kinas
cancer
research
signal
play
critic
role
vascular
develop
matur
crucial
tumor
angiogenesi
underli
mechan
activ
car
mpsc
clone
warrant
explor
tumor
vasculatur
deriv
cancer
cell
may
regul
differ
regular
vasculatur
offer
potenti
new
therapeut
target
hallmark
cancer
cell
collect
promot
surviv
prolifer
foreign
environ
suppress
oncogen
stress
includ
selfsuffici
growth
signal
insensit
antigrowth
signal
evas
apoptosi
sustain
angiogenesi
tissu
invas
metastasi
unlimit
replic
potenti
studi
demonstr
hyperexpress
suffici
car
mpsc
gain
hallmark
cancer
cell
acquisit
cicslik
properti
car
mpsc
clone
may
valuabl
cell
model
studi
properti
cic
moreov
easi
manipul
car
mpsc
clone
may
enabl
largescal
cultur
develop
new
therapeut
approach
target
cic
although
hyperexpress
induc
transform
car
mpsc
well
document
identif
natur
occur
environment
factor
induc
express
warrant
addit
research
recent
studi
report
hypox
microenviron
induc
express
activ
deregul
notabl
car
mpsc
activ
particip
tumor
angiogenesi
activ
signal
pathway
find
provid
novel
insight
regard
origin
cic
offer
new
strategi
antiangiogen
therapi
lung
cancer
human
lung
adenocarcinoma
cell
line
mous
axillari
lymph
nodevascular
epitheli
cell
line
human
embryon
kidney
cell
line
hek
obtain
bioresourc
collect
research
center
taiwan
cell
maintain
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
fb
humidifi
incub
co
car
mpsc
isol
primari
cultur
accord
carposit
express
fac
describ
previous
detail
method
describ
supplementari
method
car
mpsc
car
mpscsderiv
typei
pneumocyt
transfect
retrovir
vector
encod
briefli
retrovir
vector
plasmid
addgen
packag
plasmid
pcmvgagpolpa
pcmvvsvg
introduc
cell
use
genejuic
transfect
reagent
novagen
h
viral
supernat
pass
filter
supplement
polybren
car
mpsc
deriv
typei
pneumocyt
seed
cell
per
mm
dish
incub
viral
supernat
h
transfect
cell
cultiv
me
medium
suppli
mitomycin
c
inactiv
mef
cell
feeder
cell
cobblestonelik
coloni
form
day
day
day
coloni
manual
isol
expand
matrigel
becton
dickinson
bioscienc
supplement
medium
establish
cell
clone
clone
gener
clone
transfect
retrovir
vector
encod
gfp
briefli
retrovir
vector
plasmid
pmxspuro
gfp
addgen
packag
plasmid
pcmvgagpolpa
pcmvvsvg
introduc
cell
use
genejuic
transfect
reagent
novagen
h
viral
supernat
pass
filter
supplement
polybren
clone
seed
cell
per
mm
dish
incub
viral
supernat
h
puromycin
add
medium
gfpposit
coloni
determin
expans
refer
clone
total
rna
extract
use
trizol
invitrogen
cdna
synthesi
mmlv
rt
promega
use
accord
manufactur
instruct
revers
transcript
pcr
perform
use
taq
polymeras
invitrogen
accord
manufactur
protocol
realtim
pcr
perform
use
ht
realtim
pcr
instrument
appli
biosystem
primer
sequenc
list
supplementari
tabl
glyceraldehyd
dehydrogenas
gapdh
express
use
normal
cell
lysat
extract
ripa
buffer
pierc
quantifi
bca
protein
assay
kit
pierc
accord
manufactur
protocol
equal
amount
total
protein
separ
use
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
blot
onto
activ
polyvinyliden
difluorid
membran
millipor
block
fatfre
milk
membran
incub
primari
antibodi
list
supplementari
tabl
blot
incub
secondari
antibodi
conjug
horseradish
peroxidas
immunoreact
band
detect
enhanc
chemiluminesc
detect
millipor
express
analysi
cell
dissoci
singl
cell
wash
suspend
pb
cell
label
allophycocyanin
apc
conjug
antimous
biolegend
analyz
use
fac
calib
instrument
cell
cycl
distribut
analysi
cell
cultiv
plate
incub
h
cell
collect
wash
pb
fix
ethanol
overnight
subsequ
cell
wash
pb
resuspend
pb
contain
rnase
propidium
iodid
fac
calib
instrument
analyz
cell
cycl
distribut
gfp
express
tumor
tissu
dissoci
kit
miltenyi
biotec
use
dissoci
tumor
cell
suspens
accord
manufactur
protocol
cell
suspens
stain
apc
conjug
antimous
biolegend
subsequ
analyz
use
facscalib
instrument
aldh
activ
cell
detect
use
aldefluor
assay
kit
stemcel
technolog
accord
manufactur
protocol
cell
suspend
aldefluor
assay
buffer
contain
bodipyaminoacetaldehyd
baaa
incub
min
cell
treat
aldh
inhibitor
diethylaminobenzaldehyd
deab
neg
control
propidium
iodid
stain
identifi
nonviabl
cell
facscalib
instrument
use
analyz
aldh
activ
cell
green
fluoresc
channel
nm
telomeras
activ
measur
use
telomeras
repeat
amplif
trap
assay
cell
homogen
trap
lysi
buffer
protein
use
telomeras
reaction
along
trap
reaction
buffer
contain
mm
trishcl
ph
mm
mgcl
mm
kcl
mm
egta
deoxynucleotid
triphosph
pharmacia
label
ts
acx
primer
attomol
intern
control
primer
unit
taq
dna
polymeras
invitrogen
chap
extract
incub
min
telomeraseextend
product
amplifi
pcr
follow
condit
cycl
cycl
compris
incub
reaction
mixtur
heat
min
inactiv
telomeras
amplifi
product
resolv
polyacrylamid
gel
electrophoresi
stain
ethidium
bromid
view
uv
light
soft
agar
coloni
format
assay
perform
seed
cell
mm
tissu
cultur
dish
contain
layer
lowmelt
agarose
layer
lowmelt
agaros
addit
complet
media
ad
everi
wk
coloni
fix
crystal
violet
methanol
coloni
format
photograph
quantifi
use
light
microscopi
cell
seed
well
ultra
lowattach
plate
corn
densiti
cell
per
well
grown
serumfre
dmem
supplement
invitrogen
ngml
egf
ngml
bfgf
invitrogen
cultiv
primari
sphere
harvest
use
centrifug
dissoci
trypsin
resuspend
medium
secondari
sphere
photograph
quantifi
anim
experi
review
approv
institut
anim
care
use
committe
nation
taiwan
univers
colleg
medicin
teratoma
format
assay
cell
car
mpsc
clone
subcutan
inject
male
sever
combin
immunodefici
scid
mice
limit
dilut
transplant
experi
clone
cell
car
mpsc
cell
subcutan
inject
scid
mice
clone
wwwimpactjournalscomoncotarget
cell
deriv
tumor
experi
clone
cell
cell
subcutan
inject
scid
mice
tumor
dimens
measur
use
calip
everi
volum
cm
calcul
accord
standard
formula
length
width
end
experi
tumor
surgic
excis
photograph
metastasi
assay
cell
clone
car
mpsc
inject
later
tail
vein
scid
mice
lung
metastat
nodul
evalu
week
necropsi
histolog
examin
kaplanmei
analysi
use
compar
surviv
rate
mice
inject
clone
inject
car
mpsc
tumor
fix
formalin
subsequ
dehydr
paraffin
embed
section
tumor
section
subject
antigen
retriev
microwav
irradi
citrat
buffer
mm
ph
section
incub
primari
antibodi
overnight
immunohistochem
stain
section
incub
correspond
hrpcoupl
secondari
antibodi
room
temperatur
h
visual
use
dab
nuclei
counterstain
hematoxylin
immunofluoresc
stain
correspond
fluoresc
coupl
secondari
antibodi
perform
room
temperatur
h
nuclei
counterstain
dapi
neg
control
prepar
use
ident
condit
control
igg
use
substitut
primari
antibodi
antibodi
list
supplementari
tabl
section
examin
use
nikon
eclips
immunohistochem
stain
section
quantifi
use
tissuefax
tissuegnost
gmbh
scan
percentag
immuneposit
popul
analyz
histoquest
softwar
tissuegnost
gmbh
cell
seed
cell
per
well
plate
incub
h
cell
treat
cisplatin
sigmaaldrich
paclitaxel
sigmaaldrich
variou
concentr
h
assay
roch
perform
determin
cell
viabil
accord
manufactur
instruct
cell
viabil
express
percentag
nontreat
group
ic
valu
determin
fertil
chicken
egg
incub
atmospher
humid
day
develop
cell
load
onto
membran
implant
top
grow
cam
day
cam
fix
paraformaldehyd
photograph
use
stereomicroscop
digit
camera
branch
point
quantifi
use
nih
imag
j
softwar
angiogenesi
plugin
cell
cultiv
endotheli
cell
growth
medium
egm
lonza
cell
collect
suspend
dmem
supplement
fb
seed
matrigel
h
cell
stain
calceinam
invitrogen
imag
obtain
use
fluoresc
microscop
zeiss
car
mpsc
clone
cocultur
tube
format
matrigel
plate
mm
ibidi
dish
clone
deriv
sphere
label
green
fluoresc
tracer
calceinam
mix
cell
stain
red
fluoresc
cell
tracer
dye
sigmaaldrich
nuclei
counterstain
cellular
mixtur
seed
onto
matrigel
plate
dish
dmem
contain
fb
matrigel
tube
format
record
use
timelaps
immunofluoresc
confoc
microscopi
quantit
data
least
three
independ
experi
express
mean
standard
deviat
sd
student
ttest
use
compar
differ
group
surviv
curv
obtain
use
kaplanmei
analysi
p
consid
statist
signific
